Article Details
Retrieved on: 2021-06-15 14:21:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca Plc (NASDAQ: AZN) reported data from the STORM CHASER Phase 3 trial showing that its long-acting antibody (LAAB) combination ...
Article found on: uk.news.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here